Latest Insider Transactions at Mycotopia Therapies, Inc. (TPIA)
This section provides a real-time view of insider transactions for Mycotopia Therapies, Inc. (TPIA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Mycotopia Therapies, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Mycotopia Therapies, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 25
2025
|
Benjamin Nathaniel Kaplan CEO |
BUY
Grant, award, or other acquisition
|
Direct |
75,000,000
+44.05%
|
-
|
|
Dec 13
2024
|
Mark Croskery Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000,000
+49.96%
|
$0
$0.01 P/Share
|
|
Dec 13
2024
|
Benjamin Kaplan CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000,000
+49.69%
|
$0
$0.01 P/Share
|